(Q36734996)

16 August 2017

1 reference

12 December 2020

1 reference

PubMed publication ID

18577254

title

Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review (English)

1 reference

16 August 2017

1 reference

3 April 2019

1 reference

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

1

Elie A Akl

1 reference

16 August 2017

10

Holger J Schünemann

1 reference

16 August 2017

9

Heather O Dickinson

1 reference

16 August 2017

8

Victor Yosuico

1 reference

16 August 2017

3

Maddalena Barba

1 reference

16 August 2017

Frederiek F van Doormaal

series ordinal

2

object named as

Frederiek F van Doormaal

1 reference

16 August 2017

7

Saskia Middeldorp

1 reference

16 August 2017

Ganesh Kamath

4

1 reference

16 August 2017

Seo Young Kim

series ordinal

5

1 reference

16 August 2017

Saskia Kuipers

series ordinal

6

1 reference

16 August 2017

language of work or name

1 reference

15 May 2008

3 references

Journal of Experimental & Clinical Cancer Research

16 August 2017

3 April 2019

12 December 2020

2 references

16 August 2017

12 December 2020

27

1 reference

16 August 2017

4

1 reference

Creative Commons Attribution 2.0 Generic

16 August 2017

2 references

3 April 2019

on focus list of Wikimedia project

12 December 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1756-9966-27-4

0 references

cites work

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Oral anticoagulation may prolong survival of a subgroup of patients with cancer: a cochrane systematic review.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Heparin-induced thrombocytopenia: a review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Low-molecular-weight heparin and survival in patients with malignant disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Can low-molecular-weight heparin improve the outcome of patients with operable non-small cell lung cancer? An urgent call for research

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Measuring inconsistency in meta-analyses

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Can low-molecular-weight heparins improve outcome in patients with cancer?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Improved cancer mortality with low-molecular-weight heparin treatment: a review of the evidence

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

The complex effects of heparins on cancer progression and metastasis in experimental studies.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

The effect of low molecular weight heparin on survival in patients with advanced malignancy

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438335

The effects of unfractionated heparin on survival in patients with malignancy--a systematic review

5 September 2018

1 reference

12 December 2020

Clinical expertise in the era of evidence-based medicine and patient choice

1 reference

12 December 2020

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer

1 reference

12 December 2020

[Risk and prevention of thromboembolism complications in gynecologic malignancies]

1 reference

12 December 2020

Hemostasis and malignancy

1 reference

12 December 2020

Identifiers

DOI

10.1186/1756-9966-27-4

1 reference

Dimensions Publication ID

16 August 2017

0 references

1 reference

16 August 2017

PubMed publication ID

18577254

1 reference